Multi-tasking imatinib boosts radiotherapy for bladder tumours
Cancer drug imatinib (Glivec) could boost radiotherapy treatment to destroy bladder cancer that has spread to the bladder wall, reveals research published in Cancer Research.
Researchers at the Universities of Leeds and Oxford, co-funded by Cancer Research UK and Yorkshire Cancer Research, showed that adding imatinib to bladder cancer cells blocks an important DNA damage repair route. This makes cancer cells more responsive to radiotherapy – by preventing them from repairing radiation damage – while sparing healthy cells which have alternative survival routes.
Imatinib is a tyrosine kinase inhibitor used to treat some leukaemias and soft tissue sarcomas.
The team showed that the drug prevents a protein called RAD51 from repairing DNA damage in bladder cancer via a process called homologous recombination. A separate key DNA repair process is faulty in aggressive bladder cancer cells, but not in healthy cells. This means that both repair processes are knocked out in cancer cells but healthy cells still have one route to repair damage, avoiding radiotherapy harm.
The research suggests that imatinib could make radiotherapy better at killing aggressive bladder cancer cells with fewer side effects.
Study author Dr Anne Kiltie, Cancer Research UK scientist at the University of Oxford**, said: "These exciting results show that imatinib which is used to treat a range of cancer types may have untapped potential to treat more.
"This is early research in the laboratory so the next stage is to confirm these results in larger studies, with the hope of speeding up the development of better ways to treat bladder cancer – increasing survival with fewer side effects."
More than 10,500 people are diagnosed with bladder cancer each year in the UK with about 4,900 annual deaths from the disease.
Kathryn Scott, head of research funding at Yorkshire Cancer Research, said: "Without early stage research, treatments for bladder cancer could not be improved in this way to enhance the effectiveness of radiotherapy and give more patients hope of a cure. By understanding the molecular mechanisms behind the disease, scientists and clinicians are beginning to understand how to combine drugs in new and innovative ways and maximise their tumour killing potential. This is an exciting discovery and we look forward to seeing how it progresses."
Dr Julie Sharp, Cancer Research UK's senior science information manager, said: "This important work adds another piece in the puzzle to help our understanding of bladder cancer.
"There's a real need for new ways to treat and diagnose the disease. At diagnosis around three in 10 bladder cancers have already spread into the muscle layer of the bladder – when the disease is harder to treat successfully.
"And survival from advanced disease is still poor – around half of these patients will survive for longer than three years following diagnosis.
"Radiotherapy is a vital part of cancer treatment and we hope these latest findings can be used to make it more effective for treating bladder cancer and save more lives."
More information: Qiao, B., Kerr, M., Groselj, B., Teo, M., Knowles, M., Bristow, R., Phillips, R., & Kiltie, A. (2013). Imatinib Radiosensitizes Bladder Cancer by Targeting Homologous Recombination, Cancer Research. DOI: 10.1158/0008-5472.CAN-12-1170
Journal reference: Cancer Research
Provided by Cancer Research UK
- New treatment to reduce the relapse rate in bladder cancer patients Jan 31, 2011 | not rated yet | 0
- Adding chemo to radiotherapy halves risk of deadly bladder cancer returning Apr 23, 2012 | not rated yet | 0
- Chemotherapy plus radiation prevents bladder cancer recurrences Oct 25, 2010 | not rated yet | 0
- Some diabetes drugs may increase risk of bladder cancer Jul 03, 2012 | not rated yet | 0
- Three-in-one 'supermolecule' could detect cancer early, help destroy tumours and monitor treatment Nov 06, 2012 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
How can there be a term called "intestinal metaplasia" of stomach
7 hours ago Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
- More from Physics Forums - Medical Sciences
More news stories
An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute report.
Cancer 57 minutes ago | not rated yet | 0
The surgical management of non-small cell lung cancer (NSCLC) in U.S. hospitals varies widely depending on the race of the patient, according to a new study.
Cancer 4 hours ago | not rated yet | 0
Treatment with an Alpha-1 proteinase inhibitor (A1-PI), a naturally occurring protein that protects lung tissue from breakdown and protects the lung's elasticity, is effective in slowing the progression of emphysema in patients ...
Cancer 5 hours ago | not rated yet | 0
Scientists from Nanyang Technological University (NTU) and Lund University, Sweden, have bioengineered a novel molecule which has been proven to successfully kill tumour cells.
Cancer 5 hours ago | 5 / 5 (1) | 0
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
1 hour ago | 4.7 / 5 (3) | 0 |
Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.
10 minutes ago | not rated yet | 0 |
Children with autism showed significant improvement after six months of simple sensory exercises at home using everyday items such as scents, spoons and sponges, according to UC Irvine neurobiologists.
51 minutes ago | not rated yet | 0 |
Overweight and obese patients are significantly more likely than their normal-weight counterparts to repeatedly switch primary care doctors, a practice that disrupts continuity of care and leads to more emergency room visits, ...
52 minutes ago | not rated yet | 0
The decision to limit life support in patients in the intensive care unit (ICU) appears to be significantly influenced by physician practices and/or the culture of the hospital, suggests new findings from researchers at the ...
28 minutes ago | not rated yet | 0
Children with obstructive sleep apnea who had a common surgery to remove their tonsils and adenoids showed notable improvements in behavior, quality of life and other symptoms compared to those treated with "watchful waiting" ...
28 minutes ago | not rated yet | 0